Regulus Therapeutics Statistics
Total Valuation
CHD has a market cap or net worth of $22.32 billion. The enterprise value is $23.82 billion.
| Market Cap | 22.32B |
| Enterprise Value | 23.82B |
Important Dates
The last earnings date was Friday, August 1, 2025, before market open.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
CHD has 243.61 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 243.61M |
| Shares Outstanding | 243.61M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.65% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 88.48% |
| Float | 242.95M |
Valuation Ratios
The trailing PE ratio is 43.19 and the forward PE ratio is 25.65. CHD's PEG ratio is 3.86.
| PE Ratio | 43.19 |
| Forward PE | 25.65 |
| PS Ratio | 3.70 |
| Forward PS | 3.51 |
| PB Ratio | 5.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.99 |
| P/OCF Ratio | 20.81 |
| PEG Ratio | 3.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.80, with an EV/FCF ratio of 25.59.
| EV / Earnings | 45.35 |
| EV / Sales | 3.93 |
| EV / EBITDA | 17.80 |
| EV / EBIT | 22.07 |
| EV / FCF | 25.59 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.84 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 1.75 |
| Debt / FCF | 2.59 |
| Interest Coverage | 11.53 |
Financial Efficiency
Return on equity (ROE) is 12.07% and return on invested capital (ROIC) is 9.97%.
| Return on Equity (ROE) | 12.07% |
| Return on Assets (ROA) | 7.69% |
| Return on Invested Capital (ROIC) | 9.97% |
| Return on Capital Employed (ROCE) | 14.24% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | $91,339 |
| Employee Count | 5,750 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 5.39 |
Taxes
In the past 12 months, CHD has paid $159.10 million in taxes.
| Income Tax | 159.10M |
| Effective Tax Rate | 23.25% |
Stock Price Statistics
The stock price has decreased by -10.36% in the last 52 weeks. The beta is 0.43, so CHD's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -10.36% |
| 50-Day Moving Average | 96.59 |
| 200-Day Moving Average | 102.66 |
| Relative Strength Index (RSI) | 36.84 |
| Average Volume (20 Days) | 2,382,982 |
Short Selling Information
The latest short interest is 7.50 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 7.50M |
| Short Previous Month | 6.95M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 3.09% |
| Short Ratio (days to cover) | 3.31 |
Income Statement
In the last 12 months, CHD had revenue of $6.07 billion and earned $525.20 million in profits. Earnings per share was $2.12.
| Revenue | 6.07B |
| Gross Profit | 2.70B |
| Operating Income | 1.08B |
| Pretax Income | 1.03B |
| Net Income | 525.20M |
| EBITDA | 1.34B |
| EBIT | 1.08B |
| Earnings Per Share (EPS) | $2.12 |
Balance Sheet
The company has $923.20 million in cash and $2.41 billion in debt, giving a net cash position of -$1.49 billion or -$6.10 per share.
| Cash & Cash Equivalents | 923.20M |
| Total Debt | 2.41B |
| Net Cash | -1.49B |
| Net Cash Per Share | -$6.10 |
| Equity (Book Value) | 4.39B |
| Book Value Per Share | 18.04 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was $1.07 billion and capital expenditures -$142.20 million, giving a free cash flow of $930.60 million.
| Operating Cash Flow | 1.07B |
| Capital Expenditures | -142.20M |
| Free Cash Flow | 930.60M |
| FCF Per Share | $3.82 |
Margins
Gross margin is 44.47%, with operating and profit margins of 17.79% and 8.66%.
| Gross Margin | 44.47% |
| Operating Margin | 17.79% |
| Pretax Margin | 11.28% |
| Profit Margin | 8.66% |
| EBITDA Margin | 22.05% |
| EBIT Margin | 17.79% |
| FCF Margin | 15.34% |
Dividends & Yields
This stock pays an annual dividend of $1.18, which amounts to a dividend yield of 1.29%.
| Dividend Per Share | $1.18 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | 4.00% |
| Years of Dividend Growth | 29 |
| Payout Ratio | 55.08% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.25% |
| Earnings Yield | 2.35% |
| FCF Yield | 4.17% |
Analyst Forecast
The average price target for CHD is $108.14, which is 18.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $108.14 |
| Price Target Difference | 18.03% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 4.19% |
| EPS Growth Forecast (5Y) | 15.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 2, 2016. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 2, 2016 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CHD has an Altman Z-Score of 5.75 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.75 |
| Piotroski F-Score | 6 |